International Isotopes Rebrands as Radnostix, Emphasizing Innovation in Radioisotopes and Theranostics
- International Isotopes Inc. has rebranded as Radnostix, Inc., emphasizing its commitment to radioisotope and theranostics innovation.
- The company retains its management and operational focus while expanding its offerings in medical and industrial markets.
- Radnostix continues to operate under existing brands and maintains its stock ticker "INIS" on the OTCQB marketplace.
Radnostix, Inc.: A New Era in Radioisotope and Theranostics Innovation
International Isotopes Inc. has officially rebranded itself as Radnostix, Inc., marking a significant shift in its operational focus and identity. This change, formalized through a Certificate of Amendment filed in Texas, reflects the company’s ambition to expand its role within the radioisotope and theranostics sectors. Established in 1995, the company has transitioned from its original concentration on industrial radioisotope products to a broader array of offerings that encapsulate the evolving demands of the medical and industrial markets. CEO Shahe Bagerdjian emphasizes that the new name—Radnostix—serves as a testament to the company's mission of becoming a leading partner in these critical fields while upholding its dedication to quality, innovation, and exceptional customer service.
The rebranding to Radnostix signifies a strategic pivot rather than a complete overhaul of the company’s operations. While the name has changed, the existing management team and strategic direction remain intact, ensuring continuity in service and product delivery. Radnostix maintains its commitment to high-energy sources and stable isotopes under the INIS branding, particularly for products such as generic sodium iodide I-131, essential for treating hyperthyroidism and thyroid cancer. Additionally, Radnostix continues to produce calibration and reference standards for nuclear pharmacies and imaging systems, underscoring its robust capabilities in the radioisotope manufacturing space.
As Radnostix moves forward, it retains its operational brands, including Radqual, Radvent, Easyfill, Benchmark, and PhanQual, which represent various aspects of its comprehensive portfolio. The company’s headquarters remain in Idaho Falls, Idaho, positioning it strategically within the heart of the isotopes industry. Despite the name change, shareholders are reassured that their stock, trading under the ticker symbol "INIS" on the OTCQB marketplace, will not require any action regarding stock certificates. Future announcements regarding any potential changes to the ticker symbol are anticipated as the company continues to evolve.
In summary, Radnostix, Inc. represents a forward-thinking evolution in the radioisotope industry, aligning its brand with a broader mission in theranostics. The company’s focus on innovation and quality remains steadfast, promising to enhance its partnerships and offerings in a vital sector of healthcare and industrial applications. For more detailed information, stakeholders are encouraged to visit the newly launched website at radnostix.com.